[Federal Register Volume 59, Number 85 (Wednesday, May 4, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-10682]


[[Page Unknown]]

[Federal Register: May 4, 1994]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE
 

Manufacturer of Controlled Substances; Registration

    By Notice dated March 3, 1994, and published in the Federal 
Register on March 11, 1994 (59 FR 11625), Sanofi Winthrop LP, DBA 
Sterling Organics, 33 Riverside Avenue, Rensselaer, New York 12144, 
made application to the Drug Enforcement Administration to be 
registered as a bulk manufacturer of Meperidine (9230), a basic class 
of controlled substance listed in Schedule II.
    No comments or objections have been received. Therefore, pursuant 
to section 303 of the Comprehensive Drug Abuse Prevention and Control 
Act of 1970 and Title 21, Code of Federal Regulations, Sec. 1301.54(e), 
the Deputy Assistant Administrator, Office of Diversion Control, hereby 
orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic class of controlled 
substance listed above is granted.

    Dated: April 25, 1994.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 94-10682 Filed 5-3-94; 8:45 am]
BILLING CODE 4410-09-M